S100A4 and benign neoplasm: In the rodent model systems, elevated levels of S100A4 can only synergise with growth-promoting oncogenic products such as c-erbB-2/neu (Davies et al, 1996) or have to be expressed in benign tumours before metastasis can be induced (Lloyd et al, 1998).